Breast Cancer Risk May Rise on Decade Use of Blood Pressure Drug

Breast Cancer Risk May Rise on Decade Use of Blood Pressure Drug

JB Reed/Bloomberg

Norvasc, which is available as a generic in the U.S., generated about $1.35 billion in 2012 sales for New York-based Pfizer mostly on sales outside the U.S.